| Name | Title | Contact Details |
|---|
Exa Corporation develops, sells and supports simulation software and services to enhance product performance, reduce product development costs and improve the efficiency of design and engineering processes. Our simulation solutions enable our customers to gain crucial insights about design performance early in the design cycle, thus reducing the likelihood of expensive redesigns and late-stage engineering changes. As a result, our customers realize significant cost savings and fundamental improvements in their engineering development process. Our products include, PowerFLOW, PowerDELTA with PowerCLAY, PowerVIZ, PowerSPECTRUM, PowerACOUSTICS, PowerINSIGHT, PowerCOOL and PowerTHERM along with professional engineering consulting services. A partial customer list includes: BMW, Ford, Hyundai, Jaguar Land Rover, Kenworth, MAN, Nissan, Peterbilt, Renault, Scania, Toyota, Volkswagen, and Volvo Trucks. Founded in 1991, the company is headquartered at 55 Network Drive, Burlington, MA, USA 01803.
Ampush helps performance marketers acquire new users, generate sales, and re-engage customers on mobile. By powering full-service ad buying, management and insights, the AMP platform makes it easy for advertisers to reach people with smarter in-stream ads on Facebook, Twitter, and Google. Ampush is based in San Francisco with offices in Chicago and New York.
Ink Innovation is a provider of a unique ecosystem of blockchain, biometrics, mobile and cloud systems for the travel industry and other organizations to improve operational flow and transform passengers’ experiences and journeys worldwide.
Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.
We are committed to help you find the best company for you. Thats why weve taken the time to provide clear and easy-to-read rankings, reviews, and breakdowns of companies in over 100 different industries